Compliance Rate
Compliance Rate
25.0%
Compliant submissions
2
Incompliant submissions
6
Total trials
8
My Organizations' Clinical Trials
Showing 350 of 1120 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/03/17
End: 11/26/19
Due: 11/26/20
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 07/31/10
Due: 07/31/11
Phase: N/A
Priority: Normal
Start: 05/28/22
End: 02/18/24
Due: 02/18/25
Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast Cancer
Phase: N/A
Priority: Normal
Start: 03/01/14
End: 09/01/19
Due: 09/01/20
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 02/09/17
End: 10/31/19
Due: 10/31/20
Phase: N/A
Priority: Normal
Start: 05/31/02
End: 02/28/06
Due: 02/28/07
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 07/31/17
Due: 07/31/18
Phase: N/A
Priority: Normal
Start: 11/18/24
End: 06/15/27
Due: 06/15/28
Phase: N/A
Priority: Normal
Start: 04/30/01
End: 03/31/05
Due: 03/31/06
Phase: N/A
Priority: Normal
Start: 08/21/23
End: 08/27/26
Due: 08/27/27
Phase: N/A
Priority: Normal
Start: 10/19/17
End: 10/30/22
Due: 10/30/23
Phase: N/A
Priority: Normal
Start: 05/13/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 05/31/06
Due: 05/31/07
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 08/14/20
Due: 08/14/21
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 12/19/16
End: 10/30/23
Due: 10/30/24
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 07/01/17
End: 09/01/19
Due: 09/01/20
Phase: N/A
Priority: Normal
Start: 03/01/19
End: 03/31/22
Due: 03/31/23
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 08/31/17
Due: 08/31/18
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 04/30/20
Due: 04/30/21